DRTS

Alpha Tau Medical
DRTS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$252.41M
EV
$213.06M
Shares Outstanding
84.70M
Beta
0.98

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$8.75
P/E 2025E
-
P/Revenue 2025E
132.69x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Alpha Tau Medical Ltd.

gainify
DRTS

Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company’s ...

Sector

Healthcare

Industry

Biotechnology

CEO

Sofer, Uzi

Employees

125

IPO Date

2021-03-08

Headquarters

Kiryat Hamada Street 5, Jerusalem 9777605, Israel

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.